Document is current

Article History

Accepted: 20 March 2022

First Online: 18 June 2022

Change Date: 27 June 2022

Change Type: Update

Change Details: Springer Nature’s version of this paper was updated to correct the grammatical error in 'Introduction' section.

Compliance with Ethical Standards

:

: Teshamae Monteith has received personal compensation for serving on advisory boards for Biohaven, Allegan/Abbvie, Lundbeck, Amgen, Teva, and Impel Neuropharmaceuticals. She has also served as a site principal investigator without direct compensation for Teva, Eli Lilly, Electrocore, Amgen, and Novartis.

: This article does not contain any studies with human or animal subjects performed by the author.